Stock 4114 SYNMOSA BIOPHARMA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Company Synmosa Biopharma Corporation

Equities

4114

TW0004114004

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 23:00:00 09/05/2024 BST 		5-day change 1st Jan Change
39.55 TWD +1.15% Intraday chart for Synmosa Biopharma Corporation +2.06% +2.33%
03-29 Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
01-16 Synmosa Biopharma Corporation Announces Changes in Fifth Session of the Remuneration Committee CI

Business Summary

SYNMOSA BIOPHARMA CORPORATION is a Taiwan-based company principally engaged in the manufacture and sales of various kinds of pharmaceuticals and medical equipment. The Company's main products include respiratory drugs, cardiovascular and urinary drugs, gastrointestinal drugs, hormones, anti-tumor drugs, antibiotics and health products. The Company is also involved in the manufacture and sales of various kinds of cosmetics and animal medicines, as well as various kinds of chemical food additives and beverages. The Company distributes its products in domestic market and to overseas markets.

Sales per Business

TWD in Million2022Weight2023Weight Delta
Generic Drugs
96.5 %
4,238 96.6 % 4,961 96.5 % +17.05%
Active Pharmaceutical Ingredients
3.5 %
148 3.4 % 180 3.5 % +21.37%

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
85.0 %
3,876 88.4 % 4,368 85.0 % +12.69%
China
10.4 %
272 6.2 % 534 10.4 % +96.52%
Others
1.2 %
70 1.6 % 61 1.2 % -13.28%
Thailand
1.1 %
40 0.9 % 55 1.1 % +37.79%
Singapore
0.8 %
-- 42 0.8 % -
Malaysia
0.7 %
31 0.7 % 36 0.7 % +18.54%
United States
0.6 %
63 1.4 % 29 0.6 % -54.12%
Canada
0.3 %
35 0.8 % 15 0.3 % -55.68%

Managers

Managers TitleAgeSince
Chih Hui Lin CEO
 Chief Executive Officer - 25/08/70
Hung Chin Pai DFI
 Director of Finance/CFO - 31/03/01
Sheng Jen Yang PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Chih Hui Lin CEO
 Chief Executive Officer - 25/08/70
Wan Ju Liao BRD
 Director/Board Member 41 23/05/19
Li Wen Huang BRD
 Director/Board Member 51 23/05/19
Yu Peng Chang BRD
 Director/Board Member 43 23/05/19
Sheng Jen Yang PRN
 Corporate Officer/Principal - -
Te Chuan Fan BRD
 Director/Board Member 41 14/06/10
Hsiang Lang Liu BRD
 Director/Board Member 42 23/01/03
Xiu Mei Lin BRD
 Director/Board Member 42 23/05/19

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 415,268,897 320,998,897 ( 77.30 %) 19,373,000 ( 4.665 %) 77.30 %

Shareholders

NameEquities%Valuation
Dimensional Fund Advisors Ltd.
0.0191 %
76,566 0.0191 % 93 903 NT$
DFA Australia Ltd.
0.0146 %
58,478 0.0146 % 71 719 NT$

Company contact information

Synmosa Biopharma Corp.

11/F, No. 396, Section 1 Neihu Road

114 93, Taipei

+

http://www.synmosa.com.tw
address Synmosa Biopharma Corporation(4114)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SYNMOSA BIOPHARMA CORPORATION Stock Synmosa Biopharma Corporation
+2.33% 465M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+30.38% 684B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.51% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.36% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.30% 329B
ABBVIE INC. Stock AbbVie Inc.
+3.73% 284B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.70% 240B
NOVARTIS AG Stock Novartis AG
+8.78% 208B
ROCHE HOLDING AG Stock Roche Holding AG
-7.93% 200B
AMGEN INC. Stock Amgen Inc.
+7.68% 166B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4114 Stock
  4. Company Synmosa Biopharma Corporation